Login to Your Account

CRUK trial is a decisive move away from one-size-fits-all approach

By Nuala Moran
Staff Writer

Monday, April 21, 2014
LONDON – A new era in personalized treatment of cancer begins later this year in the UK with the opening of a phase II trial that will test at least 12 drugs in a single study. Patients with advanced lung cancer will be stratified according to the genetics of their tumors to receive one of the 12 drugs targeted to specific mutations.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription